MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Nelotanserin

CAS No. : 839713-36-9

MCE 站：Nelotanserin

产品活性：Nelotanserin 是 5-HT_2A 强有效的完全逆向激动剂，5-HT_2C 中等强度的部分反向激动剂，5-HT_2B 的弱反向激动剂，IC₅₀s 值分别为 1.7，79，791 nM。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：5-HT Receptor

In Vitro: Results from IP accumulation assays suggest that Nelotanserin is a potent 5-HT_2A full inverse agonist (IC₅₀=1.7 nM), a moderately potent 5-HT_2C partial inverse agonist (IC₅₀=79 nM) (maximal response was 62% of the response obtained for the reference inverse agonist clozapine), and a weak 5-HT_2B inverse agonist (IC₅₀=791 nM). Nelotanserin displays high affinity for recombinant human 5-HT_2A receptors (K_i=0.35 nM), moderate affinity for human 5-HT_2C receptors (K_i=100 nM), and low affinity for human 5-HT_2B receptors (2000 nM) stably expressed in HEK293 cells. The results suggest that Nelotanserin has a 262-fold higher affinity for human 5-HT_2A than 5-HT_2C receptors and a 6610-fold higher affinity for human 5-HT_2A than 5-HT_2B receptors.

In Vivo: Each compound is tested in a minimum of five rats by oral gavage with administration occurring in the middle of the inactive period, 6 h after light onset. The delta power during non-REM sleep (NREMS) is significantly different between all the analogues tested and the vehicle control. Nelotanserin (Compound 39) produces significant increases in delta power that persist for the first 4 h following dosing. Significant differences are found, however, in NREMS bout length. Nelotanserin significantly increases NREMS bout length during the first hour following dosing, and 3 does so during the second hour. In conjunction with this increased NREM bout duration, the number of NREM bouts decrease during the first hour for Nelotanserin (p<0.01) as well as for compound 15 (p<0.05).

相关产品：Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Neuronal Signaling Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Neurotransmitter Receptor Compound Library  |  Anti-Alzheimer’s Disease Compound Library  |  Harmine  |  SCH-23390 hydrochloride  |  Puerarin  |  Olanzapine  |  GTS-21 dihydrochloride  |  Thioridazine hydrochloride  |  Risperidone  |  SB-269970 hydrochloride  |  Dihydroergotamine mesylate  |  Amitriptyline hydrochloride  |  Aripiprazole  |  Ketanserin  |  WAY-100635 Maleate  |  Buspirone hydrochloride  |  Cisapride  |  Methiothepin mesylate  |  Trazodone hydrochloride  |  Pindolol  |  Quetiapine  |  Lumateperone tosylate  |  Perphenazine  |  8-OH-DPAT  |  Levomepromazine  |  SB-224289 hydrochloride  |  Volinanserin  |  Ziprasidone  |  Paliperidone  |  Sertindole  |  Alprenolol hydrochloride  |  Asenapine maleate

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。